MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    VY-AADC01 gene therapy in Parkinson’s disease: Interim results of the on-going Phase 1b PD-1101 trial

    P. Larson, K. Bankiewicz, A. Van Laar, R. Richardson, B. Ravina, A. Kells, B. Boot, A. Martin, M. Thompson, C. Christine (San Francisco, CA, USA)

    Objective: Evaluate the safety of VY-AADC01, an AAV2 gene therapy vector with human aromatic L-amino acid decarboxylase (AADC) administered bilaterally to the putamen using intraoperative…
  • 2018 International Congress

    CLOVER-DBS: A Prospective, Multi-center Clinical Study with Blinding to Evaluate a Closed Loop Programming Algorithm for Directional Leads Based on External Feedback

    A. Kuehn, G. Wenzel, C. Bruecke, L. Juarez Paz, K. Wynants, H. Scholtes, D. Blum (Berlin, Germany)

    Objective: To assess the feasibility and efficacy of a novel closed-loop programming algorithm (CLPA) for directional lead deep brain stimulation (DBS) based on objective feedback…
  • 2018 International Congress

    Activities of Daily Living and Quality of Life in Patients with Advanced Parkinson’s Disease Who Are Treated with or Planning to Use Device-Aided Treatments

    A. Fasano, K. Seppi, V. Fung, Z. Pirtosek, J.C. Parra, L. Bergmann, O. Sanchez-Soliño, B. Elibol, K. Onuk (Toronto, ON, Canada)

    Objective: To correlate activities of daily living (ADL) and quality of life (QoL) in advanced Parkinson’s disease (APD) patients with ongoing or planned device-aided treatment…
  • 2018 International Congress

    Rationale and Design of an Open-Label, Randomized, 26-Week Study Comparing Levodopa-Carbidopa Intestinal Gel to Optimized Medical Treatment on Non-Motor Symptoms in Patients with Advanced Parkinson’s Disease – INSIGHTS Study

    K. Chaudhuri, D. Weintraub, A. Antonini, W. Robieson, M. Li, K. Chatamra, J. Benesh, M. Facheris (London, United Kingdom)

    Objective: To examine levodopa-carbidopa intestinal gel, LCIG (also known as carbidopa-levodopa enteral suspension in the US), on non-motor symptoms (NMS) compared with individually-optimized, conventional PD…
  • 2018 International Congress

    An Objective Tool to Guide Target Selection for DBS in PD (GPi vs STN) – integration into Thomas Jefferson’s multidisciplinary Movement Disorders Center

    L. Meytin, TW. Liang, J. Ratliff (Philadelphia, PA, USA)

    Objective: After the creation of simple tool to aid in selection of the proper target for Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD), our…
  • 2018 International Congress

    Simple Programming Method in STN-DBS using directional lead

    K. Kimura, H. Kishida, T. Kawasaki, K. Hamada, N. Ueda, F. Tanaka (Yokohama, Japan)

    Objective: Consider a stimulation programming method that can be performed easily and in a short time. Background: Background: Since the subthalamic nucleus (STN) is a…
  • 2018 International Congress

    Outcomes of elective orthopedic surgery in Parkinson’s disease – a Nationwide study

    M. Fullard, D. Thibault, A. Willis (Philadelphia, PA, USA)

    Objective: Provide national outcomes on readmissions after elective orthopedic surgery in Parkinson’s disease (PD). Background: Advances in the treatment of PD have allowed for improvements…
  • 2018 International Congress

    Sniffing Parkinson’s in the masses: Volatilome analysis for Parkinson’s Disease diagnostics

    M. Silverdale, D. Trivedi, E. Sinclair, Y. Xu, C. Liscio, P. Banks, T. Kunath, R. Goodacre, P. Barran (Manchester, United Kingdom)

    Objective: To identify volatile compounds in the skin which can be used to provide an early diagnosis in Parkinson's disease (PD). Background: There is a…
  • 2018 International Congress

    Recruitment of Minority populations with Parkinson’s disease at an Urban Hospital

    C. Branson, S. Bissonette, T. Johnson, J. Weinberg, M. Saint-Hilaire (Boston, MA, USA)

    Objective: To evaluate diagnostic disparities in Parkinson’s disease (PD) through recruitment of underrepresented minorities into a PD screening study. Background: African-Americans are less likely than…
  • 2018 International Congress

    Reversible Extrapyramidal features as unusual presentation of central pontine myelinolysis: A case report

    S. El-Jaafary, A. Sabbah, S. Ahmed (Cairo, Egypt)

    Objective: To be acquainted with the extrapyramidal symptoms developed during the course of central pontine myelinolysis. To emphasize the importance of neuroimaging in the diagnosis…
  • « Previous Page
  • 1
  • …
  • 225
  • 226
  • 227
  • 228
  • 229
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley